2010
DOI: 10.1016/j.compchemeng.2010.02.027
|View full text |Cite
|
Sign up to set email alerts
|

Handling uncertainty in the establishment of a design space for the manufacture of a pharmaceutical product

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
55
0
2

Year Published

2011
2011
2018
2018

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(57 citation statements)
references
References 27 publications
0
55
0
2
Order By: Relevance
“…The process and the effect of the process parameters and their interactions on the product attributes must be understood in detail before process control can be successfully implemented. Therefore, the classical approach to a design space as a set of acceptable ranges for the process parameters is not sufficient, instead a multivariate model is an important tool [5,6]. Mechanistic [7][8][9], empirical [6], and a combination of both mechanical and empirical models [10] have been used for control of batch chromatography processes and proved to successfully compensate for process uncertainty and changes in process requirements.…”
Section: Introductionmentioning
confidence: 99%
“…The process and the effect of the process parameters and their interactions on the product attributes must be understood in detail before process control can be successfully implemented. Therefore, the classical approach to a design space as a set of acceptable ranges for the process parameters is not sufficient, instead a multivariate model is an important tool [5,6]. Mechanistic [7][8][9], empirical [6], and a combination of both mechanical and empirical models [10] have been used for control of batch chromatography processes and proved to successfully compensate for process uncertainty and changes in process requirements.…”
Section: Introductionmentioning
confidence: 99%
“…In another example by García-Munoz et al [18], LV models were used to set quality-driven specifications for incoming raw materials. Such specifications accounted for the inherent variability in the process and the combined effect of materials with process conditions onto product quality.…”
Section: Control Strategymentioning
confidence: 99%
“…The concept "It is important to recognize that quality cannot be tested into products; i.e., quality should be built in by design." was stated in the quality by design initiative (ICH, 2009) and widely accepted in the pharmaceutical manufacturing industry (García-Muñoz et al, 2010;Huang et al, 2010;Prpich et al, 2010;Michaels et al, 2011;Yacoub et al, 2011). Despite previous efforts in evaluating the batch-to-batch consistency of TCM after the production process (Fan et al, 2006;Xie et al, 2008;Tistaert et al, 2011;Wang et al, 2011), there is a greater need to improve the quality consistency of TCM during the manufacturing processes (Huang and Qu, 2011).…”
Section: Introductionmentioning
confidence: 99%